Dade Behring Holdings (DADE)

This is an EDITABLE stock research wiki. You can contribute by clicking on the EDIT PAGE link above or on the page icons that appear when you roll over one of the category subtitles below.

From 1

Company Information:

Company Address:

1717 Deerfield Road

Deerfield, IL 60015

Company’s Web Address: http://www.dadebehring.com/

Industry Sector:

Fiscal Year:

Dividend:


Note: this section is not editable. Please click here to report any inaccuracies.
Shares Outstanding: 85,800,000
Market Capitalization: Updating...

Income Statements
Click for: Annual Income Statement
Click for: Quarterly Income Statement

Balance Sheets
Click for: Annual Balance Sheet
Click for: Quarterly Balance Sheet

Cash Flow Statements
Click for: Annual Cash Flow Statement
Click for: Quarterly Cash Flow Statement

SEC Filings
Click for: Form 10-Ks
Click for: Form 10-Qs
Click for: Annual Proxy Statements
Link to SEC filings search: http://www.sec.gov/cgi-bin/srch-edgar

Company Overview:

Note: this section is not editable.

Dade Behring Holdings, Inc. (DADE) is a manufacturer and distributor of in vitro diagnostics (IVD) products and services for clinical laboratories. Dade Behring's products and services comprise reagents and consumables, medical diagnostic instruments, and maintenance services. These are categorized into four business segments. The chemistry diagnostics business (66% of 2006 revenue) is engaged in routine chemistry/immunochemistry, cardiac, plasma proteins, and drugs of abuse testing, as well as therapeutic drug monitoring. The company has a routine chemistry/immunochemistry instrument platform called Dimension. The hemostasis business (18%) provides tests to measure a patient's ability to form and dissolve blood clots. The microbiology diagnostics business (10%) manufactures manual and automated Identification/Antibiotic Susceptibility Testing (ID/AST) products. Microbiology diagnostics products are available under the MicroScan trade name. The infectious disease diagnostic business (5%) is engaged in bacteriology, parasitology, and virology testing, including HIV and hepatitis testing. In addition to diagnoses of diseases, these tests are used for screening, in order to ensure a safe blood supply. The remaining 1% of revenue comes from other mature products that are no longer part of the company's core business.

Read full report on Dade Behring Holdings, Inc. Company overview provided by Dade Behring Holdings, Inc. Overview

Company Products/Services/Markets:

Enter Company Products/Services Here

Strategy:

Describe Key Aspects of Company's Strategy Here

Competitors:

Enter Competitors Here

Industry Trends and News:

Enter Industry Trends and News Here

Acquisitions, Divestitures, Major Transactions, Spin-offs :

Enter Acquisitions, Divestiures, Major Transactions, Spin-offs Here

Management – Pros & Cons, Changes:

Enter Management - Pros & Cons, Changes Here

Financial Analysis:

Enter Financial Analysis Here

Valuation:

Enter Valuation Analysis and Valuation Ratios Here

  2007 2006 2005
Price/Earnings


Price/EBITDA


Price/Pre-tax Income


Price/Revenue


Investment Rationale:

Buy Rationale:

Enter Buy Rationale Here

Sell Rationale:

Enter Sell Rationale Here

Projected Financials:

Income Statement: (Paste Here)

Balance Sheet: (Paste Here)

Cash Flow Statement: (Paste Here)

Financial Ratios: (Paste Here)

Other: (Paste Here)

Discussion:

This area is for debates regarding different recommendations for this stock.

Footnotes:

See Also (links to blogs, forums, external sources, etc...):

Tags:
none
The opinions and views expressed in this document do not necessarily reflect the views or opinions of InvestingMinds. InvestingMinds did not prepare and does not endorse such content. Please note that it is intended for general circulation only and the recommendations contained herein do not take into account the specific investment objectives, financial situation or particular needs of any particular person. This document is for information purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy securities or other instruments. No part of this document may be reproduced in any manner without the written permission of InvestingMinds.
 
Images (0)
 
Comments (0)
You must login to post a comment.